Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+26.67%)
At close: Sep 2, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) Accumulated Expenses (2022 - 2024)

Exousia Bio (LMMY) posted Accumulated Expenses of $1211.0 for Q3 2024, little changed sequentially from $1211.0 in Q2 2024, and down 72.16% YoY from $4350.0 in Q3 2023.

Analysis

Exousia Bio (LMMY) Accumulated Expenses (2022 - 2024) Analysis & Trends

Exousia Bio (LMMY) has 2 years of Accumulated Expenses data on file, last reported at $1211.0 in Q3 2024.

  • Quarterly Accumulated Expenses fell 72.16% year-over-year to $1211.0 in Q3 2024, while the trailing twelve-month figure through Aug 2024 was $1211.0 (down 72.16% YoY) and the FY2024 annual result came in at $1211.0, up 98.52% from the prior year.
  • Accumulated Expenses held at $1211.0 in Q3 2024 per LMMY's latest filing, from $1211.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $5972.0 in Q1 2024, with the low at $610.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 New Oriental Education & Technology 94.81 Bn 92.07 Bn 812.22 Mn
2 Laureate Education 5.12 Bn 4.96 Bn 237.67 Mn
3 Graham Holdings 4.84 Bn 3.59 Bn 777.03 Mn
4 Covista 4.55 Bn 4.14 Bn 284.63 Mn
5 Grand Canyon Education 3.99 Bn 3.72 Bn 204.08 Mn
6 Stride 3.71 Bn 2.75 Bn 217.28 Mn
7 McGraw Hill 2.54 Bn 2.34 Bn 439.20 Mn
8 Perdoceo Education 2.10 Bn 797.06 Mn 162.46 Mn
9 TAL Education 1.94 Bn -740.46 Mn 227.32 Mn
10 Exousia Bio 368,824.87 368,824.87 -62,108.00
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2024 12,495.00
May 31, 2024 11,079.00
Feb 29, 2024 5,972.00
Nov 30, 2023 8,250.00
Aug 31, 2023 4,350.00
May 31, 2023 5,422.00
Feb 28, 2023 4,011.00
May 31, 2022 333.00